Morin hydrate: A potential antioxidant in minimizing the free-radicals- mediated damage to cardiovascular cells by anti-tumor drugs

Life Sciences

Volumn 67, Issue 1, 2000, Pages 91-99

  Kok, L D S ^a   Wong, Y P ^a   Wu, T W ^b   Chan, H C ^a   Kwok, T T ^a   Fung, K P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti tumor drug; Antioxidant; Cardiovascular cell; Morin hydrate

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; DOXORUBICIN; FREE RADICAL; MANGANESE SUPEROXIDE DISMUTASE; MITOMYCIN C; MORIN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENDOTHELIUM CELL; ERYTHROCYTE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0034717023     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00605-6     Document Type: Article

References (20)

1. J.W. Lown, Adv. Free Radical Biol. Med. 1 225 (1985).
2. B.K. Sinha, Chem. Biol. Interact. 69 293-317 (1989).
3. B. Ghosh, C.D. Hanevold, K. Dobashi, J.K. Orak and I. Singh, Free Radic. Biol. Med. 21 533-40 (1996).
4. T.W. Wu, L.H. Zeng, J. Wu and K.P. Fung, Life Sci. 53 PL213-PL218 (1993).
5. D.L. Spector, R.D. Goldman and L.A. Leinwand, Cells: A Laboratory Manual, 11.3-11.6, Cold Spring Harbor Laboratory Press: U.S.A (1998).
6. D. Gerlier and N. Thomasset, J. Immunol. Methods 94 57-63 (1986).
7. H. Sugiyama, K.P. Fung and T.W. Wu, Life Sci. 53 PL39-PL43 (1993).
8. M. Miki, H. Tamai, M. Mino, Y. Yamamoto and E. Niki, Arch. Biochem. Biophys. 258 373-80 (1987).
9. G.M. Wahl, S.L. Berger and A.R. Kimmel, Methods Enzymol. 152 399-407 (1987).
10. R.M. Viero and V.A. Soares, Ren. Fail. 20 565-71 (1998).
11. A.M. Meadowcroft, C.J. Gilbert, D. Maravich-May and S.L. Hayward, Am. J. Health Syst. Pharm. 55 1898-902 (1998).
12. T.W. Wu, L.H. Zeng, J. Wu and K.P. Fung, Biochem. Pharmacol. 47 1099-1103 (1994).
13. T.W. Wu, K.P. Fung, C.C. Yang and R.D. Weisel, Life Sci. 57 PL51-PL56 (1995).
14. D.A. O'Keefe and D.J. Schaeffer, J. Vet. Intern. Med. 6 276-82 (1992).
15. N.A. Sarvazyan, A. Askari and W.H. Huang, Life Sci. 57 1003-10 (1995).
16. S.A. Van Acker, E. Boven, K. Kuiper, D.J. Van Der Berg, J.A. Grimbergen, K. Kramer, A. Bast and W.J. Van Der Vijgh, Clin. Cancer Res. 3 1747-54 (1997).
17. G.P. Stathopoulos, N.A. Malamos, I. Dontas, G. Deliconstantinos, D. Perrea-Kotsareli, and P.E. Karayannacos, Anticancer Res. 18 4387-92 (1998).
18. J. Vora, B.A. Khaw, J. Narula, and M. Boroujerdi, J. Pharm. Pharmacol. 48 940-4 (1996).
19. B.C. Husken, J. De Jong, B. Beekman, R.C. Onderwater, W.J. Van Der Vijgh, and A. Bast, Cancer Chemother. Pharmacol. 37 55-62 (1995).
20. S.A. Van Acker, D.J. Van Den Berg, M.N. Tromp, D.H. Griffioen, W.P. Van Bennekom, W.J. Van Der Vijgh and A. Bast, Free Radic. Biol. Med. 20 331-42 (1996).